Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program

14/10/2024 9 min
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program

Listen "Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program"

Episode Synopsis

In this episode, Dr. Valentin Fuster discusses a pivotal study on inflammation's role in obesity-related heart failure with preserved ejection fraction, highlighting findings from the STEP heart failure program. The research reveals that semaglutide improves heart failure symptoms and reduces inflammation across varying baseline CRP levels, suggesting cardiovascular benefits that extend beyond weight loss alone.

More episodes of the podcast JACC This Week